Industry News
Bollywood Stars Face Regulatory Notices Over Tobacco-Linked 'Surrogate' Advertising
Imagine the FDA sending formal notices to Tom Cruise, Denzel Washington, and Timothée Chalamet over a single commercial. That's roughly the scale of what happened in India this week: Maharashtra's Food and Drug Administration (FDA) issued nine-page show-cause notices to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff — three of Bollywood's biggest names — over their appearances in ads for "Vimal Elaichi," a cardamom-mouth-freshener brand that regulators say is really a stand-in for banned tobacco products.
The "Surrogate Advertising" Game
India bans advertising for pan masala containing tobacco (gutkha), and Maharashtra prohibits the products themselves. The workaround the industry found is called surrogate advertising: market a legal product — cardamom seeds, mouth fresheners, even bottled water — under the exact brand name of the restricted one, with the same logo, colors, and celebrity faces. The brand stays on billboards and cricket broadcasts; the banned product gets the halo.
The notices, issued August 11 by the FDA's Greater Mumbai division and widely reported August 16, 2026, allege the Vimal Elaichi campaign "prima facie" amounts to indirect or surrogate promotion of the prohibited Vimal pan masala line. The agency cited India's Food Safety and Standards Act, its 2018 advertising regulations, and the Consumer Protection Act. This scrutiny mirrors how Philip Morris AI Campaign Ruled as Illegal Advertising by Dutch Watchdog in other jurisdictions.
The three actors — served at Devgn's Juhu home, Khan's famous Mannat residence, and Shroff's production company — have 15 days to answer a pointed question: is Vimal Elaichi a genuine, independently sold product, or a brand costume? They've been asked to produce endorsement agreements and proof of due diligence. Regulators are increasingly looking at how Tobacco Products & Smoking Accessories are marketed globally.
Real Money, Real Precedent
These are notices, not verdicts — no one has been fined. However, the stakes are concrete: under India's consumer-protection framework, misleading-endorsement penalties run from about 1 million to 5 million rupees, and endorsers can be banned from advertising work for up to three years. This legal tension is similar to when the Court Revives Class Action Over Natural American Spirit 'Natural' Labels regarding brand messaging.
"Regulators counter that when a 'mouth freshener' ad's real function is keeping a gutkha brand famous, everyone involved understands the arrangement — and India's oral-cancer burden... is the reason the rules exist."
There is also precedent for the reputational cost: in 2022, Akshay Kumar — then one of the same campaign's faces — publicly apologized after fan backlash, quit the brand, and pledged to donate his fee. The counterpoint the actors will likely raise is that elaichi (cardamom) products are legally sold, and celebrity endorsers argue they cannot police a conglomerate's entire brand architecture. This debate over brand extensions is common in the industry, much like how Cigarillos & Small Cigars are often marketed alongside larger counterparts.
Why It Resonates Beyond India
The U.S. solved this fight a generation ago through the 1998 tobacco settlement and subsequent FDA rules that stripped cigarette brands from merchandise, events, and celebrity campaigns. What India is testing now is whether those principles can reach the gray zone of lookalike products — a question that echoes in current U.S. debates about branding in nicotine pouches, hemp products, and beyond.
Advertising regulators everywhere watch these cases, because every restricted category eventually invents its own "elaichi." Whether it is the selling nicotine in America: a 2026 mid-year regulatory reality check or international enforcement, the focus remains on how brands communicate with the public. We have seen similar shifts in how Hookah Tobacco & Shisha Flavors are presented to consumers.
The Bottom Line
Three megastars, one nine-page notice, and fifteen days to answer. Whatever the outcome, India's regulators have made surrogate tobacco advertising a front-page issue in the world's most star-obsessed film market — and given every other country's ad enforcement agencies a case study to watch. For more industry updates, visit our Tobacco Guide: Pipe Tobacco, Wraps, Cigarillos & Pouches — All Articles.